Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (4): 255-256.
WANG Wei-bo1, WANG Hai-ying1, SHI Chun-huan1, GAO Xue-de1, CHEN Xiao-yuan1, LI Zhen-qing1, WANG Ji -mei1, ZHANG Cui-fang2
Received:2018-05-29
Revised:2018-05-29
Online:2018-04-20
Published:2018-05-29
CLC Number:
WANG Wei-bo, WANG Hai-ying, SHI Chun-huan, GAO Xue-de, CHEN Xiao-yuan, LI Zhen-qing, WANG Ji -mei, ZHANG Cui-fang. One Case of Toxic Epidermal Necrolysis Induced by Vancomycin Hydrochloride for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(4): 255-256.
| [1] Tartarone A, Lerose R.Stevens-johnson syndrome and toxic epidermal necrolysis: what do we know[J]. Ther Drug Monit, 2010, 32(6): 669-672. [2] Y eh Y W. Persistent hiccups associated w ith sw itching from risperidone to aripiprazole in a schizophrenic patientw ith cerebral palsy[J]. Clin N europharm acol, 2011, 34(4): 135-136. [3] 吴明东, 丁汀, 魏妙华, 等. 151 例住院患者万古霉素用药分析[J]. 药物流行病学杂志, 2013, 22(1): 7. [4] 孙捍卫, 降文兰, 朱铁梁. 万古霉素的国内应用和不良反应概况[J]. 武警医学院学报, 2009, 18(9): 816-818. [5] Sahai J,Healy D P,Shelton M J, et al.Comparison of vancomycin- and teicoplanin- induced histamine release and red man syndrome[J]. Antimicrob Agents Chemother, 1990, 34(5): 765-769. [6] 黄天国, 宋爱华, 葛英. 万古霉素致红人综合征3例[J]. 临床合理用药杂志, 2013, 6(7): 100-101. [7] 欧燕, 毛艳, 周俊, 等. 万古霉素致严重不良反1例[J]. Herald of Medicine, 2016, 35(9): 1020. [8] 谭慧心. 万古霉素2001-2013年不良反应报道文献的分析[J]. 现代药物与临床, 2013, 28(4): 598-601. [9] 陶宏, 曹国文, 佟光明, 等. 1例万古霉素致药热的会诊案例分析[J]. 华西药学杂志, 2013, 28(6): 654. [10] 褚燕琦, 王之舟, 沈江华, 等. 基于《中国万古霉素治疗药物监测指南》对我院万古霉素药物治疗监测现状评价研究[J]. 中国药物警戒, 2017, 14(7): 435-438. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
